Yüklüyor......
Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology
2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) is a promising tool to support the evaluation of response to either target therapies or immunotherapy with immune checkpoint inhibitors both in clinical trials and, in selected patients, at the single patient’s level. The present review aims to discuss...
Kaydedildi:
| Yayımlandı: | Medicina (Kaunas) |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466359/ https://ncbi.nlm.nih.gov/pubmed/32722205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina56080373 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|